Anti-D treatment in thrombocytopenia refractory to conventional therapies
Adorno, G.; Lo Pinto, F.R.; Cox, M.C.; Bruno, A.; Masi, M.; Stipa, E.; Montanaro, M.; Papa, G.
Haematologica 77(1): 97-98
1992
ISSN/ISBN: 0390-6078 PMID: 1327999 Document Number: 401263
Document emailed within 1 workday
Related Documents
Jamadar, N.; Nagoba, B.; Davane, M.; Ahmed, A.; Tangsal, A. 2019: Citric acid treatment of oral ulcers refractory to conventional treatment: a case study Journal of Wound Care 28(7): 461-463Cobo-Ibáñez, T.; Muñoz-Fernández, S.; Hidalgo-Barrero, V.; Martín-Mola, E. 2006: Medium-long term treatment with infliximab and methotrexate in posterior and/or chronic uveitis refractory to conventional treatment Medicina Clinica 126(1): 34-35
Downer, S.M.; Cody, M.M.; McCluskey, P.; Wilson, P.D.; Arnott, S.J.; Lister, T.A.; Slevin, M.L. 1994: Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment BMJ 309(6947): 86-89
Labarca, Cán.; Massardo, L.; García, P.I.; Jacobelli, S. 2003: Effectiveness of infliximab in patients with inflammatory arthritis refractory to conventional treatment Revista Medica de Chile 131(10): 1157-1164
Pita-Ramírez, L.; Hurtado-Monroy, R.; Labardini-Méndez, J. 1992: Treatment of chronic refractory idiopathic thrombocytopenia purpura. 10 years experience at the Salvador Zubiran National Institute of Nutrition Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 44(4): 501-506
Roy, S.; Wilkins, J.; March, C.M.; Solera, N.C.; Galvan, N.I.; Ressler, R.L.; Cendejas, K.A.; Neal, J.; Azen, C.G.; Essin, D.J. 1990: A comparison of the efficacy and safety of ceftizoxime with doxycycline versus conventional CDC therapies in the treatment of upper genital tract infection with or without a mass Clinical Therapeutics 12(Suppl): 53-73
Stewart, J.A. 1988: Safety and tolerance of trimetrexate: results of a phase II multicenter study in patients with metastatic cancer refractory to conventional therapy or for which no conventional therapy exists Seminars in Oncology 15(2 Suppl. 2): 10-16
Au, S-Chung.; Madani, A.; Alhaddad, M.; Alkofide, M.; Gottlieb, A.B. 2013: Comparison of the efficacy of biologics versus conventional systemic therapies in the treatment of psoriasis at a comprehensive psoriasis care center Journal of drugs in dermatology: JDD 12(8): 861-866
Mele, A.; Sparaventi, G.; Guiducci, B.; Nicolini, G.; d'Adamo, F.; Leopardi, G.; Delfini, C.; Piccaluga, P.; Visani, G. 2004: Gemtuzumab ozogamicin plus cytarabine determines complete remission in acute myeloid leukemia refractory to a double conventional treatment: a case report Haematologica 89(6 Suppl): Ecr18
Wood, L.; du Toit, J.M.; Baker, P.M.; Jacobs, P.; Dent, D.M. 1999: Management of refractory immune thrombocytopenia South African Medical Journal 89(6): 572-574
Barzilai, D.; Rimm, A. 2000: Conventional medical care and unconventional therapies JAMA 283(1): 56; Author Reply 57
Maksymowych, W.P.; Inman, R.D.; Gladman, D.; Thomson, G.; Stone, M.; Karsh, J.; Russell, A.S. 2003: Canadian Rheumatology Association Consensus on the use of anti-tumor necrosis factor-alpha directed therapies in the treatment of spondyloarthritis Journal of Rheumatology 30(6): 1356-1363
Misinski, M. 1987: Role of conventional management and alternative therapies in limiting infarct size in acute myocardial infarction Heart and Lung: the Journal of Critical Care 16(6 Pt 2): 746-755
Gotoh, M. 2009: Treatment and rehabilitation programs for young alcoholics: acquiring the ability through group therapies and cognitive-behavioral therapies to communicate with others to lead a new life Nihon Arukoru Yakubutsu Igakkai Zasshi 44(5): 579-603
Wakita, A.; Murase, T.; Uchida, T.; Fujiwara, Y.; Tanaka, M.; Ohkita, T. 1992: Mitoxantrone and conventional-dose cytosine arabinoside for relapsed and refractory acute leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(5): 653-657
Sciascia, S.; Giachino, O.; Roccatello, D. 2012: Prevention of thrombosis relapse in antiphospholipid syndrome patients refractory to conventional therapy using intravenous immunoglobulin Clinical and Experimental Rheumatology 30(3): 409-413
Marotta, G.; Bigazzi, C.; Lenoci, M.; Tozzi, M.; Bocchia, M.; Lauria, F. 2000: Low-dose fludarabine and cyclophosphamide in elderly patients with B-cell chronic lymphocytic leukemia refractory to conventional therapy Haematologica 85(12): 1268-1270
Wei, J.Y.; Bulkley, B.H.; Schaeffer, A.H.; Greene, H.L.; Reid, P.R. 1978: Mitral-valve prolapse syndrome and recurrent ventricular tachyarrhythmias: a malignant variant refractory to conventional drug therapy Annals of Internal Medicine 89(1): 6-9
Akaza, H.; Aiba, K.; Isonishi, S.; Ikeda, T.; Ohashi, Y.; Kawai, K.; Saijo, N.; Saeki, T.; Sone, S.; Tsukagoshi, S.; Tsuruo, T.; Boku, N.; Kato, M.; Mikami, O.; Blackledge, G.; Stribling, D. 2002: Globalization of anti-cancer therapies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(2): 205-214
Paxéus, N. 2004: Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, beta-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment Water science and technology: a journal of the International Association on Water Pollution Research 50(5): 253-260